Compare VALN & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | EVC |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.2M | 683.9M |
| IPO Year | 2021 | 2000 |
| Metric | VALN | EVC |
|---|---|---|
| Price | $5.70 | $6.74 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $12.25 | N/A |
| AVG Volume (30 Days) | 21.9K | ★ 1.2M |
| Earning Date | 11-12-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | N/A | ★ 47.59 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $536,034,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $87.65 | N/A |
| P/E Ratio | ★ N/A | $21.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.75 | $1.95 |
| 52 Week High | $12.18 | $13.74 |
| Indicator | VALN | EVC |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 25.76 |
| Support Level | $5.10 | $2.89 |
| Resistance Level | $6.60 | $10.09 |
| Average True Range (ATR) | 0.20 | 0.30 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 23.73 | 18.33 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.